Volume 4.04 | Feb 3

Immunology of Infectious Disease News 4.04 February 3, 2016
Immunology of Infectious Disease News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Like Us on Facebook  IIDN on Twitter
 
TOP STORY
HIV Is Still Growing, Even When Undetectable in the Blood
Scientists found that HIV is still replicating in lymphoid tissue, even when it is undetectable in the blood of patients on antiretroviral drugs. The findings provide a critical new perspective on how HIV persists in the body despite potent antiretroviral therapy. [Press release from Northwestern University discussing online prepublication in Nature] Press Release | Abstract
Isolate particle-free human CD4+CD127lowCD25+ regulatory T cells (Tregs) in less than one hour. Request a sample today.
 
PUBLICATIONS (Ranked by impact factor of the journal)
Most Microbe-Specific Naïve CD4+ T Cells Produce Memory Cells during Infection
Investigators found that in mice, essentially all microbe-specific naïve cells produced memory cells during infection. Different clonal memory cell populations had different B cell or macrophage helper compositions that matched effector cell populations generated much earlier in the response. [Science] Abstract

Glutamylation of the DNA Sensor cGAS Regulates Its Binding and Synthase Activity in Antiviral Immunity
Investigators found that deficiency in the carboxypeptidase CCP5 or CCP6 led to susceptibility to DNA viruses. CCP5 and CCP6 were required for activation of the transcription factor IRF3 and interferons. [Nat Immunol] Abstract

Dysbiosis-Induced IL-33 Contributes to Impaired Antiviral Immunity in the Genital Mucosa
Researchers demonstrated that dysbiosis caused by oral antibiotic treatment directly impairs antiviral immunity following viral infection of the vaginal mucosa. Antibiotic-treated mice succumbed to mucosal herpes simplex virus type 2 infection more rapidly than water-fed mice, and also showed delayed viral clearance at the site of infection. [Proc Natl Acad Sci USA] Abstract

The Adhesion GPCR BAI1 Mediates Macrophage ROS Production and Microbicidal Activity against Gram-Negative Bacteria
Scientists found that brain-specific angiogenesis inhibitor 1 (BAI1) triggered the killing of the internalized bacteria by stimulating the production of reactive oxygen species. When engaged by bacteria, BAI1 activated Rac1 to stimulate the activity of the NADPH oxidase complex Nox2 in macrophages. [Sci Signal] Abstract

Combined Local and Systemic Immunization Is Essential for Durable T-Cell Mediated Heterosubtypic Immunity against Influenza A Virus
Adenoviral vectors expressing flu nucleoprotein have previously been found to induce short-term protection in mice. Researchers confirm that systemic immunization rapidly induced heterosubtypic protection predominantly mediated by CD8 T cells, but within three months clinical protection completely disappeared. [Sci Rep] Full Article

HIV

Actin Dynamics Regulates Dendritic Cell-Mediated Transfer of HIV-1 to T Cells
Scientists performed a shRNA screen of several hundred genes involved in organelle and membrane trafficking in immature human monocyte-derived dendritic cells. They identified TSPAN7 and DNM2, which control actin nucleation and stabilization, as having important and distinct roles in limiting HIV-1 endocytosis and in maintaining virus particles on dendrites, which is required for efficient transfer to T lymphocytes. [Cell]
Abstract | Graphical Abstract

Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression
Researchers found that human blood innate lymphoid cells (ILCs) were severely depleted during acute viremic HIV-1 infection and that ILC numbers did not recover after resolution of peak viremia. ILC numbers were preserved by antiretroviral therapy, but only if initiated during acute infection. [Immunity]
Abstract | Graphical Abstract | Press Release

Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques
Investigators longitudinally determined the levels and functions of IL-17, IL-22 and IL-17/IL-22 producing CD4+ T-cells in blood, lymph node and colorectum of SIV-infected rhesus macaques, as well as how they recover during effective ART and are affected by ART interruption. [PLoS Pathog] Full Article

Prevention of SHIV Transmission by Topical IFN-β Treatment
The authors hypothesized that topically applied type 1 interferons might stimulate vaginal innate responses that could protect against HIV transmission. Vaginal administration of interferon (IFN)-β resulted in marked local changes in immune cell phenotype, increasing immune activation and HIV co-receptor expression, yet provided significant protection from simian/human immunodeficiency virus (SHIV) acquisition as IFN response genes were also upregulated. [Mucosal Immunol] Abstract

Potent In Vitro Antiviral Activity of Cistus incanus Extract against HIV and Filoviruses Targets Viral Envelope Proteins
Researchers demonstrated that Cistus incanus (Ci) herbal products inhibit human immunodeficiency virus (HIV) infections in vitro. Ci extract inhibited clinical HIV-1 and HIV-2 isolates, and, importantly, a virus isolate with multiple drug resistances, confirming broad anti-HIV activity. [Sci Rep] Full Article | Press Release

Subscribe to our sister publications: Human Immunology News and Immune Regulation News!

Isolate rat immune cells in as little as 13 minutes. Request a sample today.
 
REVIEWS
Type I Interferons in Viral Control and Immune Regulation
Systematic characterization of the cellular populations and intricacies of type 1 interferon signaling that promote pathology or immune suppression during acute and persistent viral infections, respectively, should inform the development of treatments and modalities to control viral associated pathologies. [Curr Opin Virol] Abstract

HIV Susceptibility of Human Antigen-Specific CD4 T Cells in AIDS Pathogenesis and Vaccine Response
The authors examine recent data regarding the HIV susceptibility of antigen-specific CD4 T cells induced during infection or HIV vaccination and discuss its potential impact on HIV acquisition risk posed by HIV vaccination. [Expert Rev Vaccines] Abstract

Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field.
 
INDUSTRY NEWS
DTRA Awards $9.7 Million Contract for Drug Development Aimed at Viral Threats
The Defense Threat Reduction Agency (DTRA) has awarded Emory University a $9.7 million contract to develop drugs to treat infections caused by emerging and man-made viral threats. Under the contract, the DTRA funds will be used to advance the development of the lead drug candidate. [Emory University] Press Release

MaxMind Gives $100K to GW Center for Neglected Tropical Diseases to Create Gene Drive to Eliminate Schistosomiasis
MaxMind has partnered with the George Washington University’s Research Center for Neglected Diseases of Poverty to end schistosomiasis through gene drive technology. MaxMind gave a $100K gift to support the establishment of a lab-based project that aims to eliminate schistosomiasis and the disease-causing parasites responsible for the infection, through a cutting-edge gene drive approach. [George Washington University] Press Release

Merck Receives FDA Approval of ZEPATIER™ (Elbasvir and Grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults following Priority Review
Merck announced that the U.S. Food and Drug Administration (FDA) has approved ZEPATIER™ for the treatment of adult patients with chronic hepatitis C virus genotype (GT) 1 or GT4 infection, with or without ribavirin, following priority review by the FDA. [Merck & Co., Inc.] Press Release

Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial
Inovio Pharmaceuticals, Inc. announced the beginning of recruitment for its collaborative vaccine study for MERS (Middle East Respiratory Syndrome). Inovio and GeneOne Life Science Inc. are co-developing Inovio’s MERS vaccine in partnership with the Walter Reed Army Institute of Research, where the trial is being conducted. [Inovio Pharmaceuticals, Inc.] Press Release

From our sponsor:
Quickly find the whole-blood frequencies of human and mouse immune cell types.
Download the app.
 
POLICY NEWS
Worries about Brain Damage in Infants Linked to Zika Leads WHO to Declare a Public Health Emergency
Increasingly strong links between the spread of Zika virus and microcephaly in newborns led the World Health Organization (WHO) to declare a Public Health Emergency of International Concern. [ScienceInsider] Editorial

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW International Conference on Human & Translational Immunology
September 16-21, 2016
Rhodes, Greece

Visit our events page to see a complete list of events in the immunology of infectious disease community.
 
JOB OPPORTUNITIES
NEW Senior Scientist – Immunology (Bavarian Nordic GmbH)

Senior Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.)

Global Medical Leader – Infectious Diseases (F. Hoffmann-La Roche)

Professor – Highly Infectious Diseases (Pennsylvania State University)

Research Associate – Bacterial Infection in the Context of Antimicrobial Resistance (Imperial College London)

Postdoctoral Position – Immunological Impact of Endogenous Retroviruses (The Francis Crick Institute)

Postdoctoral Position – Immunology (Indiana University School of Medicine)

Postdoctoral Position – Host-Microbial Interactions (University of Oxford)

Postdoctoral Position – Hantavirus and Inflammation Research (Karolinska Institutet)

Research Technician I – HIV Vaccine Trials (Fred Hutchinson Cancer Research Center)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immunology of Infectious Disease News: Archives | Events | Contact Us